• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING Back to Search Results
Model Number 3851
Device Problems Difficult to Remove (1528); Device-Device Incompatibility (2919)
Patient Problem No Code Available (3191)
Event Date 05/15/2020
Event Type  Injury  
Event Description
It was reported that removal difficulties were encountered and device interaction occurred.In 2017, percutaneous coronary intervention was performed at another hospital with a 3.5/12 synergy stent placed from the left main trunk (lmt) to the proximal left anterior descending (lad) artery.In may 2020, severe stenosis was observed distal of the stent that was originally placed.The 75% stenosed target lesion was located in the moderately tortuous and severely calcified mid lad.A 10mmx3.00mm wolverine coronary cutting balloon was used for treatment and dilated at 8 atmospheres.During removal, severe resistance was met and upon pulling the device together with the wire, the previously placed stent came out together with the wolverine balloon.There were no changes to the patient's condition.Intravascular ultrasound was performed and another wolverine was used.A non-bsc stent was deployed on lad#7(mid lad) treatment section, and in lad#6(proximal lad/lmt) where the previously placed synergy stent had been accidentally removed.No further complications nor injuries were reported.The physician additionally noted that it seemed that mal-apposition occurred of the previous stent in the proximal area of the stent that was placed upon pre-ivus and the balloon may have caught in that area.
 
Manufacturer Narrative
Device evaluation by mfr: wolverine device3.00x10, catheter batch#24824881 038 was returned for analysis.The device was returned with the balloon inside a severly stretched and damaged stent.For investigation purposes the stent was remove from the device.A visual examination identified that the balloon was not folded which indicates that the balloon was subjected to positive pressure.The device was returned with the balloon inside a damaged stent.One of the blades of the device was found to have gone through the stent.After removing the damaged stent the returned device was attached to an encore inflation unit and positive pressure was applied, the balloon was inflated to its rate of burst pressure for 30 seconds using digital timer without issue.A vacuum was then applied.The inflation device was verified at the rated burst pressure, before and after use with calibrated pressure gauge.This inflation to rate of burst pressure was repeated three times with no leaks or drop in pressure noted.No issues were identified with balloon inflation or the balloon material.A visual and microscopic examination found all of the blades to be present, undamaged and fully bonded to the balloon material.The device was received with the balloon inside a severely damaged stent.The proximal end of one of the blades and its blade pad had been forced through the first row of proximal struts of the damaged stent.This would suggest that the balloon of the device was not fully deflated on removal from the patient.A microscopic examination identified damaged to the tip.This type of damage is consistent with the device encountering resistasnce when attempting to cross the lesion.A visual and microscopic examination found no issue with the markerbands.A visual and tactile examination found the hypotube to be kinked at more than one location.This type of damage is consistent with the device encountering resistance and the user applying excessive force when attempting to cross the lesion.No other issues were noted with the returned device which may have potentially contributed to the complaint incident.
 
Event Description
It was reported that removal difficulties were encountered and device interaction occurred.In 2017, percutaneous coronary intervention was performed at another hospital with a 3.5/12 synergy stent placed from the left main trunk (lmt) to the proximal left anterior descending (lad) artery.In (b)(6) 2020, severe stenosis was observed distal of the stent that was originally placed.The 75% stenosed target lesion was located in the moderately tortuous and severely calcified mid lad.A 10mmx3.00mm wolverine coronary cutting balloon was used for treatment and dilated at 8 atmospheres.During removal, severe resistance was met and upon pulling the device together with the wire, the previously placed stent came out together with the wolverine balloon.There were no changes to the patient's condition.Intravascular ultrasound was performed and another wolverine was used.A non-bsc stent was deployed on lad#7(mid lad) treatment section, and in lad#6(proximal lad/lmt) where the previously placed synergy stent had been accidentally removed.No further complications nor injuries were reported.The physician additionally noted that it seemed that mal-apposition occurred of the previous stent in the proximal area of the stent that was placed upon pre-ivus and the balloon may have caught in that area.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WOLVERINE CORONARY CUTTING BALLOON MONORAIL
Type of Device
CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10146628
MDR Text Key194951526
Report Number2134265-2020-06863
Device Sequence Number1
Product Code NWX
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/11/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/12/2022
Device Model Number3851
Device Catalogue Number3851
Device Lot Number0025205129
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/01/2020
Date Manufacturer Received07/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SYNERGY DRUG-ELUTING STENT; SYNERGY DRUG-ELUTING STENT; SYNERGY DRUG-ELUTING STENT
Patient Outcome(s) Required Intervention;
Patient Age63 YR
Patient Weight63
-
-